L&C BIO Co.,LTD (KOSDAQ:290650)
South Korea flag South Korea · Delayed Price · Currency is KRW
51,200
-1,400 (-2.66%)
Jul 29, 2026, 10:50 AM KST

L&C BIO Co.,LTD Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
43,84930,88818,28714,9496,59217,382
Short-Term Investments
04,6004,59940,1834,000-
Trading Asset Securities
4,7891,3331,2524,0601,7252,238
Cash & Short-Term Investments
48,63836,82124,13759,19312,31619,620
Cash Growth
244.97%52.55%-59.22%380.60%-37.23%-28.25%
Accounts Receivable
28,24024,72421,73518,22313,19312,718
Other Receivables
1,190901.0329,722911.84220.48153.76
Receivables
29,49025,68652,04619,89413,55313,242
Inventory
41,66142,81746,77946,28834,20312,312
Prepaid Expenses
-1,5441,9971,59882.37800
Other Current Assets
35,23632,3205,0963,3844,1291,659
Total Current Assets
155,025139,188130,056130,35764,28447,632
Property, Plant & Equipment
113,787106,60497,01774,65553,13817,895
Long-Term Investments
30,95540,21228,54745,54673,62634,966
Goodwill
123,899123,899197,307-2,320-
Other Intangible Assets
3,7993,8961,9321,4561,2551,150
Long-Term Deferred Tax Assets
32,93032,6239,704---
Other Long-Term Assets
6,3939,8956,4294,3464,1025,058
Total Assets
467,087456,637472,150262,230199,725107,401

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
4,1761,3992,3311,7452,9101,021
Accrued Expenses
-1,472815.93467.84331.95163.99
Short-Term Debt
68,32167,22598,43679,1549,508-
Current Portion of Long-Term Debt
15,16715,191166.56166.56166.56125.56
Current Portion of Leases
-1,5371,2601,396967.16607.2
Current Income Taxes Payable
818.461,033203.5513,460759.14699.92
Current Unearned Revenue
-77.2320.8320.990.15-
Other Current Liabilities
155,288149,86251,3175,4284,0963,017
Total Current Liabilities
243,770237,795154,551101,83818,7385,635
Long-Term Debt
4,0064,02020,065541.3270,5655,445
Long-Term Leases
-4,2263,973876.13738.05652.85
Pension & Post-Retirement Benefits
1,2801,1481,457822.64965.031,069
Long-Term Deferred Tax Liabilities
296.11296.1163.09899.75591.671,194
Other Long-Term Liabilities
4,519618.25766.8396.37305.91139.15
Total Liabilities
253,870248,104180,876105,37591,90414,136

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
12,47012,35511,38811,38811,38811,388
Additional Paid-In Capital
94,77878,83553,43853,42751,98843,875
Retained Earnings
100,71999,336218,74683,59336,86533,342
Treasury Stock
-7,982-8,302-3,873-3,890-6,358-6,358
Comprehensive Income & Other
2,85215,9991,2032,4274,0692,773
Total Common Equity
202,838198,224280,902146,94597,95285,021
Minority Interest
10,37910,31010,3729,9119,8698,245
Shareholders' Equity
213,217208,533291,274156,856107,82193,265
Total Liabilities & Equity
467,087456,637472,150262,230199,725107,401

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
87,49392,199123,90082,13481,9456,831
Net Cash (Debt)
-38,855-55,378-99,763-22,942-69,62812,789
Net Cash Growth
-----3.88%
Net Cash Per Share
-1615.69-2329.11-4397.77-927.97-3069.36573.56
Filing Date Shares Outstanding
24.624.6222.6822.6822.6822.68
Total Common Shares Outstanding
24.624.6222.6822.6822.6822.68
Working Capital
-88,745-98,607-24,49528,51945,54641,998
Book Value Per Share
8246.228051.7112382.776477.654317.943747.89
Tangible Book Value
75,14070,42981,663145,48994,37783,871
Tangible Book Value Per Share
3054.762860.773599.896413.474160.333697.20
Land
58,11757,13453,56054,55634,1162,744
Buildings
32,71228,27122,6067,4577,4576,312
Machinery
21,87920,65817,51414,54212,2878,773